GSE58827: Dynamics of the Mouse Liver
Name | miRBASE accession |
---|---|
mmu-miR-30a-5p
|
MIMAT0000128 |
mmu-miR-30b-5p
|
MIMAT0000130 |
mmu-miR-30c-5p
|
MIMAT0000514 |
mmu-miR-30d-5p
|
MIMAT0000515 |
mmu-miR-30e-5p
|
MIMAT0000248 |
mmu-miR-384-5p
|
MIMAT0004745 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_79301623 | 6.45 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr2_+_163054682 | 6.21 |
ENSMUST00000018005.3
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr10_+_79927039 | 6.01 |
ENSMUST00000019708.5
ENSMUST00000105377.1 |
Arid3a
|
AT rich interactive domain 3A (BRIGHT-like) |
chr10_-_45470201 | 5.41 |
ENSMUST00000079390.6
|
Lin28b
|
lin-28 homolog B (C. elegans) |
chr2_-_114052804 | 5.17 |
ENSMUST00000090269.6
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr4_-_134018829 | 5.15 |
ENSMUST00000051674.2
|
Lin28a
|
lin-28 homolog A (C. elegans) |
chr11_-_12037391 | 4.79 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr2_-_168767029 | 4.65 |
ENSMUST00000075044.3
|
Sall4
|
sal-like 4 (Drosophila) |
chr9_-_108190352 | 4.14 |
ENSMUST00000035208.7
|
Bsn
|
bassoon |
chr14_-_60086832 | 4.04 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr1_-_58504946 | 3.23 |
ENSMUST00000027198.5
|
Orc2
|
origin recognition complex, subunit 2 |
chr5_+_13399309 | 3.23 |
ENSMUST00000030714.7
ENSMUST00000141968.1 |
Sema3a
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
chr2_-_131562283 | 3.19 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr11_-_116581446 | 3.19 |
ENSMUST00000082152.4
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr18_-_62179948 | 3.15 |
ENSMUST00000053640.3
|
Adrb2
|
adrenergic receptor, beta 2 |
chr3_+_146404631 | 3.12 |
ENSMUST00000106153.2
ENSMUST00000039021.4 ENSMUST00000106151.1 ENSMUST00000149262.1 |
Ssx2ip
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr19_+_54045182 | 3.10 |
ENSMUST00000036700.5
|
Adra2a
|
adrenergic receptor, alpha 2a |
chr9_+_70678950 | 3.06 |
ENSMUST00000067880.6
|
Adam10
|
a disintegrin and metallopeptidase domain 10 |
chrX_+_85574018 | 3.00 |
ENSMUST00000048250.3
ENSMUST00000137438.1 ENSMUST00000146063.1 |
Tab3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr3_-_100489324 | 2.97 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr1_-_95667555 | 2.92 |
ENSMUST00000043336.4
|
St8sia4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr2_-_18998126 | 2.89 |
ENSMUST00000006912.5
|
Pip4k2a
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
chr15_-_96642883 | 2.87 |
ENSMUST00000088452.4
|
Slc38a1
|
solute carrier family 38, member 1 |
chr8_+_106168857 | 2.83 |
ENSMUST00000034378.3
|
Slc7a6
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 |
chr2_-_153241402 | 2.73 |
ENSMUST00000056924.7
|
Plagl2
|
pleiomorphic adenoma gene-like 2 |
chr19_+_38930909 | 2.66 |
ENSMUST00000025965.5
|
Hells
|
helicase, lymphoid specific |
chr17_-_56830916 | 2.65 |
ENSMUST00000002444.7
ENSMUST00000086801.5 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr16_-_92826004 | 2.64 |
ENSMUST00000023673.7
|
Runx1
|
runt related transcription factor 1 |
chr3_+_103102604 | 2.64 |
ENSMUST00000173206.1
|
Dennd2c
|
DENN/MADD domain containing 2C |
chr8_-_9771018 | 2.64 |
ENSMUST00000110969.3
|
Fam155a
|
family with sequence similarity 155, member A |
chr18_-_52529847 | 2.62 |
ENSMUST00000171470.1
|
Lox
|
lysyl oxidase |
chr18_-_20746402 | 2.60 |
ENSMUST00000070080.5
|
B4galt6
|
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
chr4_+_17853451 | 2.60 |
ENSMUST00000029881.3
|
Mmp16
|
matrix metallopeptidase 16 |
chr12_-_54986328 | 2.54 |
ENSMUST00000038926.6
|
Baz1a
|
bromodomain adjacent to zinc finger domain 1A |
chr1_-_176807124 | 2.52 |
ENSMUST00000057037.7
|
Cep170
|
centrosomal protein 170 |
chr5_+_76840597 | 2.51 |
ENSMUST00000120639.2
ENSMUST00000163347.1 ENSMUST00000121851.1 |
C530008M17Rik
|
RIKEN cDNA C530008M17 gene |
chr11_+_23256001 | 2.49 |
ENSMUST00000020538.6
ENSMUST00000109551.1 ENSMUST00000102870.1 ENSMUST00000102869.1 |
Xpo1
|
exportin 1, CRM1 homolog (yeast) |
chr13_+_30749226 | 2.44 |
ENSMUST00000021784.2
ENSMUST00000110307.1 |
Irf4
|
interferon regulatory factor 4 |
chr7_+_67952817 | 2.44 |
ENSMUST00000005671.8
|
Igf1r
|
insulin-like growth factor I receptor |
chr6_+_29694204 | 2.37 |
ENSMUST00000046750.7
ENSMUST00000115250.3 |
Tspan33
|
tetraspanin 33 |
chr12_+_32378692 | 2.32 |
ENSMUST00000172332.2
|
Ccdc71l
|
coiled-coil domain containing 71 like |
chr6_-_30958990 | 2.30 |
ENSMUST00000101589.3
|
Klf14
|
Kruppel-like factor 14 |
chr13_+_104178797 | 2.28 |
ENSMUST00000022225.5
ENSMUST00000069187.5 |
Trim23
|
tripartite motif-containing 23 |
chr10_-_123196916 | 2.26 |
ENSMUST00000020334.7
|
Usp15
|
ubiquitin specific peptidase 15 |
chr11_-_59964936 | 2.25 |
ENSMUST00000062405.7
|
Rasd1
|
RAS, dexamethasone-induced 1 |
chr4_+_21776261 | 2.24 |
ENSMUST00000065111.8
ENSMUST00000040429.5 ENSMUST00000148304.1 |
Usp45
|
ubiquitin specific petidase 45 |
chr9_-_85327110 | 2.20 |
ENSMUST00000034802.8
|
Fam46a
|
family with sequence similarity 46, member A |
chr5_+_72647779 | 2.19 |
ENSMUST00000087212.3
|
Nipal1
|
NIPA-like domain containing 1 |
chr9_-_95845215 | 2.15 |
ENSMUST00000093800.2
|
Pls1
|
plastin 1 (I-isoform) |
chr12_-_118301429 | 2.12 |
ENSMUST00000026367.9
|
Sp4
|
trans-acting transcription factor 4 |
chr7_+_30121915 | 2.12 |
ENSMUST00000098596.3
ENSMUST00000153792.1 |
Zfp382
|
zinc finger protein 382 |
chr16_+_19760232 | 2.12 |
ENSMUST00000079780.3
ENSMUST00000164397.1 |
B3gnt5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
chr13_+_91461050 | 2.10 |
ENSMUST00000004094.8
ENSMUST00000042122.8 |
Ssbp2
|
single-stranded DNA binding protein 2 |
chr1_-_191026181 | 2.07 |
ENSMUST00000085635.4
|
Mfsd7b
|
major facilitator superfamily domain containing 7B |
chr2_+_112379204 | 2.05 |
ENSMUST00000028552.3
|
Katnbl1
|
katanin p80 subunit B like 1 |
chr14_+_84443553 | 2.05 |
ENSMUST00000071370.5
|
Pcdh17
|
protocadherin 17 |
chr3_+_130180882 | 2.04 |
ENSMUST00000106353.1
ENSMUST00000080335.4 |
Col25a1
|
collagen, type XXV, alpha 1 |
chr1_+_43445736 | 2.04 |
ENSMUST00000086421.5
ENSMUST00000114744.1 |
Nck2
|
non-catalytic region of tyrosine kinase adaptor protein 2 |
chr7_-_98178254 | 2.02 |
ENSMUST00000040971.7
|
Capn5
|
calpain 5 |
chrX_+_20425688 | 2.02 |
ENSMUST00000115384.2
|
Phf16
|
PHD finger protein 16 |
chr18_-_54990124 | 1.95 |
ENSMUST00000064763.5
|
Zfp608
|
zinc finger protein 608 |
chr3_+_102734496 | 1.93 |
ENSMUST00000029451.5
|
Tspan2
|
tetraspanin 2 |
chr12_+_16894894 | 1.93 |
ENSMUST00000020904.6
|
Rock2
|
Rho-associated coiled-coil containing protein kinase 2 |
chr2_-_66124994 | 1.93 |
ENSMUST00000028378.3
|
Galnt3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 |
chr13_+_75707484 | 1.93 |
ENSMUST00000001583.6
|
Ell2
|
elongation factor RNA polymerase II 2 |
chr4_-_149698698 | 1.93 |
ENSMUST00000038859.7
ENSMUST00000105690.2 |
Pik3cd
|
phosphatidylinositol 3-kinase catalytic delta polypeptide |
chr17_+_47630690 | 1.93 |
ENSMUST00000024779.8
|
Usp49
|
ubiquitin specific peptidase 49 |
chr9_+_118506226 | 1.92 |
ENSMUST00000084820.4
|
Golga4
|
golgi autoantigen, golgin subfamily a, 4 |
chr17_-_51832666 | 1.91 |
ENSMUST00000144331.1
|
Satb1
|
special AT-rich sequence binding protein 1 |
chrX_+_23693043 | 1.91 |
ENSMUST00000035766.6
ENSMUST00000101670.2 |
Wdr44
|
WD repeat domain 44 |
chr9_+_75071148 | 1.90 |
ENSMUST00000123128.1
|
Myo5a
|
myosin VA |
chr8_-_57653023 | 1.88 |
ENSMUST00000034021.5
|
Galnt7
|
UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 |
chrX_-_78583882 | 1.83 |
ENSMUST00000114025.1
ENSMUST00000134602.1 ENSMUST00000114024.2 |
Prrg1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
chr13_+_111686178 | 1.76 |
ENSMUST00000109272.2
|
Mier3
|
mesoderm induction early response 1, family member 3 |
chr4_+_11191726 | 1.74 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr3_+_136670076 | 1.74 |
ENSMUST00000070198.7
|
Ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isoform |
chr4_-_148130678 | 1.74 |
ENSMUST00000030862.4
|
Draxin
|
dorsal inhibitory axon guidance protein |
chr13_-_117025505 | 1.73 |
ENSMUST00000022239.6
|
Parp8
|
poly (ADP-ribose) polymerase family, member 8 |
chr5_+_21543525 | 1.73 |
ENSMUST00000035651.4
|
Lrrc17
|
leucine rich repeat containing 17 |
chr19_+_41593363 | 1.71 |
ENSMUST00000099454.3
|
AI606181
|
expressed sequence AI606181 |
chrX_+_42149288 | 1.71 |
ENSMUST00000115073.2
ENSMUST00000115072.1 |
Stag2
|
stromal antigen 2 |
chr3_+_28263205 | 1.70 |
ENSMUST00000159236.2
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr2_-_73529725 | 1.69 |
ENSMUST00000094681.4
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr1_+_9798123 | 1.69 |
ENSMUST00000168907.1
ENSMUST00000166384.1 |
Sgk3
|
serum/glucocorticoid regulated kinase 3 |
chrX_-_51205773 | 1.69 |
ENSMUST00000114875.1
|
Mbnl3
|
muscleblind-like 3 (Drosophila) |
chr13_-_28953690 | 1.69 |
ENSMUST00000067230.5
|
Sox4
|
SRY-box containing gene 4 |
chr3_-_89960562 | 1.67 |
ENSMUST00000069805.7
|
Atp8b2
|
ATPase, class I, type 8B, member 2 |
chr4_+_140700487 | 1.67 |
ENSMUST00000071169.2
|
Rcc2
|
regulator of chromosome condensation 2 |
chr17_-_80207299 | 1.66 |
ENSMUST00000063417.9
|
Srsf7
|
serine/arginine-rich splicing factor 7 |
chr11_+_43528759 | 1.66 |
ENSMUST00000050574.6
|
Ccnjl
|
cyclin J-like |
chr1_+_51289106 | 1.65 |
ENSMUST00000051572.6
|
Sdpr
|
serum deprivation response |
chr2_+_13573927 | 1.65 |
ENSMUST00000141365.1
ENSMUST00000028062.2 |
Vim
|
vimentin |
chr6_+_4903298 | 1.64 |
ENSMUST00000035813.2
|
Ppp1r9a
|
protein phosphatase 1, regulatory (inhibitor) subunit 9A |
chr1_-_119053619 | 1.64 |
ENSMUST00000062483.8
|
Gli2
|
GLI-Kruppel family member GLI2 |
chr16_-_15594507 | 1.63 |
ENSMUST00000115776.1
ENSMUST00000115777.3 |
Ube2v2
|
ubiquitin-conjugating enzyme E2 variant 2 |
chr10_+_108162358 | 1.62 |
ENSMUST00000070663.5
|
Ppp1r12a
|
protein phosphatase 1, regulatory (inhibitor) subunit 12A |
chr1_+_128103297 | 1.62 |
ENSMUST00000036288.4
|
R3hdm1
|
R3H domain containing 1 |
chr8_+_13339656 | 1.62 |
ENSMUST00000170909.1
|
Tfdp1
|
transcription factor Dp 1 |
chr5_-_89883321 | 1.61 |
ENSMUST00000163159.1
ENSMUST00000061427.5 |
Adamts3
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
chr13_+_55635002 | 1.61 |
ENSMUST00000172272.1
ENSMUST00000099479.3 |
Ddx46
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
chr6_-_57825144 | 1.56 |
ENSMUST00000114297.2
|
Vopp1
|
vesicular, overexpressed in cancer, prosurvival protein 1 |
chr1_-_23922283 | 1.56 |
ENSMUST00000027339.7
|
Smap1
|
small ArfGAP 1 |
chr10_+_111164794 | 1.55 |
ENSMUST00000105275.1
ENSMUST00000095310.1 |
Osbpl8
|
oxysterol binding protein-like 8 |
chr2_+_22895482 | 1.55 |
ENSMUST00000053729.7
|
Pdss1
|
prenyl (solanesyl) diphosphate synthase, subunit 1 |
chr2_-_74578875 | 1.54 |
ENSMUST00000134168.1
ENSMUST00000111993.2 ENSMUST00000064503.6 |
Lnp
|
limb and neural patterns |
chr3_-_103791537 | 1.53 |
ENSMUST00000118317.1
|
Hipk1
|
homeodomain interacting protein kinase 1 |
chr11_+_53567361 | 1.52 |
ENSMUST00000057330.8
ENSMUST00000120613.2 ENSMUST00000173744.1 ENSMUST00000118353.2 |
Kif3a
|
kinesin family member 3A |
chr10_-_13324160 | 1.51 |
ENSMUST00000105545.4
|
Phactr2
|
phosphatase and actin regulator 2 |
chr2_+_153741274 | 1.51 |
ENSMUST00000028981.8
|
Mapre1
|
microtubule-associated protein, RP/EB family, member 1 |
chrX_-_57338598 | 1.50 |
ENSMUST00000033468.4
ENSMUST00000114736.1 |
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr13_-_100104064 | 1.49 |
ENSMUST00000038104.5
|
Bdp1
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB |
chr12_+_71015966 | 1.48 |
ENSMUST00000046305.5
|
Arid4a
|
AT rich interactive domain 4A (RBP1-like) |
chr17_+_69156791 | 1.48 |
ENSMUST00000112680.1
ENSMUST00000080208.5 |
Epb4.1l3
|
erythrocyte protein band 4.1-like 3 |
chr14_-_65262391 | 1.46 |
ENSMUST00000131309.1
|
Fzd3
|
frizzled homolog 3 (Drosophila) |
chr13_-_55831378 | 1.46 |
ENSMUST00000021968.6
|
Pitx1
|
paired-like homeodomain transcription factor 1 |
chr6_+_71707561 | 1.45 |
ENSMUST00000121469.1
|
Reep1
|
receptor accessory protein 1 |
chr5_+_130144861 | 1.44 |
ENSMUST00000040616.2
|
Kctd7
|
potassium channel tetramerisation domain containing 7 |
chr5_-_25498702 | 1.44 |
ENSMUST00000173073.1
ENSMUST00000045291.7 |
Kmt2c
|
lysine (K)-specific methyltransferase 2C |
chr4_+_48585135 | 1.43 |
ENSMUST00000030032.6
|
Tmeff1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr5_+_65763518 | 1.43 |
ENSMUST00000113738.1
|
N4bp2
|
NEDD4 binding protein 2 |
chr3_+_94478831 | 1.43 |
ENSMUST00000029784.5
|
Celf3
|
CUGBP, Elav-like family member 3 |
chr6_-_131388417 | 1.41 |
ENSMUST00000032309.6
ENSMUST00000087865.2 |
Ybx3
|
Y box protein 3 |
chr13_+_20090538 | 1.41 |
ENSMUST00000072519.5
|
Elmo1
|
engulfment and cell motility 1 |
chr1_-_38129618 | 1.40 |
ENSMUST00000027251.6
|
Rev1
|
REV1 homolog (S. cerevisiae) |
chr13_+_106947104 | 1.40 |
ENSMUST00000022203.8
|
Dimt1
|
DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) |
chr3_+_31095052 | 1.39 |
ENSMUST00000118470.1
ENSMUST00000029194.5 ENSMUST00000123532.1 ENSMUST00000117728.1 |
Skil
|
SKI-like |
chr12_-_76822510 | 1.39 |
ENSMUST00000021459.7
|
Rab15
|
RAB15, member RAS oncogene family |
chr7_+_123214808 | 1.39 |
ENSMUST00000033035.6
|
Slc5a11
|
solute carrier family 5 (sodium/glucose cotransporter), member 11 |
chr9_-_65580040 | 1.38 |
ENSMUST00000068944.7
|
Plekho2
|
pleckstrin homology domain containing, family O member 2 |
chr14_-_99046110 | 1.36 |
ENSMUST00000042662.8
|
Mzt1
|
mitotic spindle organizing protein 1 |
chr12_+_59066908 | 1.36 |
ENSMUST00000021381.4
|
Pnn
|
pinin |
chr4_-_59549314 | 1.35 |
ENSMUST00000148331.2
ENSMUST00000030076.5 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr9_+_25252439 | 1.35 |
ENSMUST00000115272.2
ENSMUST00000165594.2 |
Sept7
|
septin 7 |
chr16_+_17233560 | 1.35 |
ENSMUST00000090190.5
ENSMUST00000115698.2 |
Hic2
|
hypermethylated in cancer 2 |
chr10_-_44458715 | 1.34 |
ENSMUST00000039174.4
|
Prdm1
|
PR domain containing 1, with ZNF domain |
chr2_-_126876209 | 1.34 |
ENSMUST00000103224.3
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7 |
chr2_+_121955964 | 1.33 |
ENSMUST00000036647.6
|
Ctdspl2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
chr16_-_76373827 | 1.33 |
ENSMUST00000121927.1
|
Nrip1
|
nuclear receptor interacting protein 1 |
chr9_-_96631487 | 1.33 |
ENSMUST00000128346.1
ENSMUST00000034984.6 |
Rasa2
|
RAS p21 protein activator 2 |
chr7_-_62420139 | 1.32 |
ENSMUST00000094340.3
|
Mkrn3
|
makorin, ring finger protein, 3 |
chr3_+_79591356 | 1.32 |
ENSMUST00000029382.7
|
Ppid
|
peptidylprolyl isomerase D (cyclophilin D) |
chr15_-_73184840 | 1.32 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr3_+_141465564 | 1.31 |
ENSMUST00000106236.2
ENSMUST00000075282.3 |
Unc5c
|
unc-5 homolog C (C. elegans) |
chr13_-_69739845 | 1.30 |
ENSMUST00000065118.5
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr5_+_140505550 | 1.30 |
ENSMUST00000043050.8
ENSMUST00000124142.1 |
Chst12
|
carbohydrate sulfotransferase 12 |
chr9_+_65908967 | 1.29 |
ENSMUST00000034949.3
ENSMUST00000154589.1 |
Csnk1g1
|
casein kinase 1, gamma 1 |
chr12_+_4917376 | 1.28 |
ENSMUST00000045664.5
|
Atad2b
|
ATPase family, AAA domain containing 2B |
chr1_-_74544275 | 1.27 |
ENSMUST00000044260.4
|
Usp37
|
ubiquitin specific peptidase 37 |
chr10_+_50592669 | 1.27 |
ENSMUST00000035606.8
|
Ascc3
|
activating signal cointegrator 1 complex subunit 3 |
chr14_-_20546512 | 1.27 |
ENSMUST00000022355.4
ENSMUST00000161445.1 ENSMUST00000159027.1 |
Ppp3cb
|
protein phosphatase 3, catalytic subunit, beta isoform |
chr12_-_112929415 | 1.27 |
ENSMUST00000075827.3
|
Jag2
|
jagged 2 |
chr15_-_64312636 | 1.27 |
ENSMUST00000177083.1
ENSMUST00000177371.1 |
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
chr17_-_12769605 | 1.26 |
ENSMUST00000024599.7
|
Igf2r
|
insulin-like growth factor 2 receptor |
chr16_-_31201150 | 1.26 |
ENSMUST00000058033.7
|
Acap2
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
chr11_+_31872100 | 1.25 |
ENSMUST00000020543.6
ENSMUST00000109412.2 |
Cpeb4
|
cytoplasmic polyadenylation element binding protein 4 |
chr3_+_28781305 | 1.25 |
ENSMUST00000060500.7
|
Eif5a2
|
eukaryotic translation initiation factor 5A2 |
chr11_+_102604370 | 1.25 |
ENSMUST00000057893.5
|
Fzd2
|
frizzled homolog 2 (Drosophila) |
chr2_-_60125651 | 1.24 |
ENSMUST00000112550.1
|
Baz2b
|
bromodomain adjacent to zinc finger domain, 2B |
chr2_+_165655237 | 1.22 |
ENSMUST00000063433.7
|
Eya2
|
eyes absent 2 homolog (Drosophila) |
chr4_-_136835843 | 1.22 |
ENSMUST00000105846.2
ENSMUST00000059287.7 ENSMUST00000105845.2 |
Ephb2
|
Eph receptor B2 |
chr2_-_153529941 | 1.20 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chrX_+_112604274 | 1.19 |
ENSMUST00000071814.6
|
Zfp711
|
zinc finger protein 711 |
chr1_-_144004142 | 1.19 |
ENSMUST00000127206.1
|
Rgs2
|
regulator of G-protein signaling 2 |
chr1_-_155972887 | 1.18 |
ENSMUST00000138762.1
ENSMUST00000124495.1 |
Cep350
|
centrosomal protein 350 |
chr8_-_105827190 | 1.17 |
ENSMUST00000041400.5
|
Ranbp10
|
RAN binding protein 10 |
chr3_-_125938537 | 1.17 |
ENSMUST00000057944.7
|
Ugt8a
|
UDP galactosyltransferase 8A |
chr1_-_63114516 | 1.17 |
ENSMUST00000097718.2
|
Ino80d
|
INO80 complex subunit D |
chr1_-_106714217 | 1.16 |
ENSMUST00000112751.1
|
Bcl2
|
B cell leukemia/lymphoma 2 |
chr16_+_87698904 | 1.15 |
ENSMUST00000026703.5
|
Bach1
|
BTB and CNC homology 1 |
chr15_-_50889691 | 1.15 |
ENSMUST00000165201.2
ENSMUST00000184458.1 |
Trps1
|
trichorhinophalangeal syndrome I (human) |
chr19_+_18670780 | 1.13 |
ENSMUST00000025632.9
|
2410127L17Rik
|
RIKEN cDNA 2410127L17 gene |
chrX_+_138914422 | 1.13 |
ENSMUST00000064937.7
ENSMUST00000113052.1 |
Nrk
|
Nik related kinase |
chr7_+_82867327 | 1.13 |
ENSMUST00000082237.5
|
Mex3b
|
mex3 homolog B (C. elegans) |
chr1_+_130717320 | 1.13 |
ENSMUST00000049813.4
|
Yod1
|
YOD1 OTU deubiquitinating enzyme 1 homologue (S. cerevisiae) |
chr5_-_20882072 | 1.12 |
ENSMUST00000118174.1
|
Phtf2
|
putative homeodomain transcription factor 2 |
chr7_+_120917744 | 1.12 |
ENSMUST00000033173.7
ENSMUST00000106483.2 |
Polr3e
|
polymerase (RNA) III (DNA directed) polypeptide E |
chr15_+_80711292 | 1.11 |
ENSMUST00000067689.7
|
Tnrc6b
|
trinucleotide repeat containing 6b |
chr12_+_85599047 | 1.11 |
ENSMUST00000177587.1
|
Jdp2
|
Jun dimerization protein 2 |
chr2_-_45113255 | 1.10 |
ENSMUST00000068415.4
ENSMUST00000127520.1 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr18_+_24205303 | 1.09 |
ENSMUST00000000430.7
|
Galnt1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
chr12_+_113185877 | 1.09 |
ENSMUST00000058491.6
|
Tmem121
|
transmembrane protein 121 |
chr14_-_67008834 | 1.09 |
ENSMUST00000111115.1
ENSMUST00000022634.8 |
Bnip3l
|
BCL2/adenovirus E1B interacting protein 3-like |
chr11_+_46055973 | 1.08 |
ENSMUST00000011400.7
|
Adam19
|
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
chr7_-_34313531 | 1.07 |
ENSMUST00000108074.1
|
4931406P16Rik
|
RIKEN cDNA 4931406P16 gene |
chr3_-_104818224 | 1.06 |
ENSMUST00000002297.5
|
Mov10
|
Moloney leukemia virus 10 |
chr4_+_8691303 | 1.05 |
ENSMUST00000051558.3
|
Chd7
|
chromodomain helicase DNA binding protein 7 |
chr5_+_121397936 | 1.04 |
ENSMUST00000042163.8
|
Naa25
|
N(alpha)-acetyltransferase 25, NatB auxiliary subunit |
chr11_-_49712674 | 1.04 |
ENSMUST00000020624.6
ENSMUST00000145353.1 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr16_-_32247152 | 1.04 |
ENSMUST00000042732.5
|
Fbxo45
|
F-box protein 45 |
chr3_-_100685431 | 1.03 |
ENSMUST00000008907.7
|
Man1a2
|
mannosidase, alpha, class 1A, member 2 |
chr1_+_151755339 | 1.03 |
ENSMUST00000059498.5
|
Edem3
|
ER degradation enhancer, mannosidase alpha-like 3 |
chr12_+_65036319 | 1.03 |
ENSMUST00000120580.1
|
Prpf39
|
PRP39 pre-mRNA processing factor 39 homolog (yeast) |
chr5_+_86804214 | 1.02 |
ENSMUST00000119339.1
ENSMUST00000120498.1 |
Ythdc1
|
YTH domain containing 1 |
chr2_+_31572701 | 1.02 |
ENSMUST00000055244.6
|
Fubp3
|
far upstream element (FUSE) binding protein 3 |
chr8_+_39005827 | 1.00 |
ENSMUST00000167992.1
|
Tusc3
|
tumor suppressor candidate 3 |
chr17_+_72836678 | 1.00 |
ENSMUST00000045174.5
|
Ypel5
|
yippee-like 5 (Drosophila) |
chr7_+_88430257 | 1.00 |
ENSMUST00000107256.2
|
Rab38
|
RAB38, member of RAS oncogene family |
chrX_+_137049586 | 1.00 |
ENSMUST00000047852.7
|
Fam199x
|
family with sequence similarity 199, X-linked |
chr13_+_13437602 | 1.00 |
ENSMUST00000005532.7
|
Nid1
|
nidogen 1 |
chr9_+_108826320 | 0.99 |
ENSMUST00000024238.5
|
Celsr3
|
cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.4 | 4.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.2 | 10.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.1 | 3.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.9 | 2.6 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.8 | 4.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.8 | 2.4 | GO:0042231 | interleukin-10 biosynthetic process(GO:0042091) interleukin-13 biosynthetic process(GO:0042231) regulation of interleukin-10 biosynthetic process(GO:0045074) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.8 | 7.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.6 | 3.9 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.6 | 2.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.6 | 2.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 1.7 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.5 | 1.6 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.5 | 2.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 1.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.5 | 2.0 | GO:1903898 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 1.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.5 | 1.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.5 | 3.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 2.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.9 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.5 | 2.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 5.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.3 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.4 | 3.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 1.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 4.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 1.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.7 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 2.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 1.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.4 | 1.6 | GO:0060032 | notochord regression(GO:0060032) |
0.4 | 1.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 2.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.4 | 0.4 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
0.4 | 1.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.4 | 1.1 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.4 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 0.7 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 1.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 3.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 1.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 2.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.7 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.3 | 1.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 3.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.3 | 1.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 1.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.9 | GO:0010716 | regulation of collagen catabolic process(GO:0010710) negative regulation of extracellular matrix disassembly(GO:0010716) |
0.3 | 0.9 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.3 | 1.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 0.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.3 | 1.9 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 1.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 3.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 2.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 1.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.3 | 1.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 1.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 1.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 2.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.0 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.2 | 4.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 1.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.7 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.2 | 1.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 0.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.9 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) neurofilament bundle assembly(GO:0033693) |
0.2 | 1.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.4 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 0.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 1.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 2.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.2 | 2.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 2.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 3.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.2 | 1.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.5 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.4 | GO:1901355 | response to rapamycin(GO:1901355) |
0.1 | 0.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) pentose catabolic process(GO:0019323) |
0.1 | 2.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.1 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.5 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 1.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 2.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 1.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 1.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 6.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 1.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 3.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 1.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 1.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 1.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 4.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.6 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.6 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.9 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 1.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 2.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 1.7 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 1.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 1.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.1 | 2.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.8 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 1.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 1.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 1.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 1.7 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 1.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.7 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.2 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 1.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 1.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.5 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 1.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.8 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.7 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.2 | 6.2 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 3.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.6 | 2.5 | GO:0008623 | CHRAC(GO:0008623) |
0.6 | 1.9 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.6 | 1.7 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.5 | 1.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.5 | 3.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 1.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 5.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.3 | GO:0005940 | septin ring(GO:0005940) |
0.4 | 1.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 0.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 2.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 2.2 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 1.0 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 2.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.8 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 2.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.1 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.1 | 0.5 | GO:0097059 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 7.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.0 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 2.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 3.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 7.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 1.0 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 1.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 3.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.1 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 3.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 3.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 1.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 1.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 6.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 14.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 1.8 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 2.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 6.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.9 | 2.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.8 | 3.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 2.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.1 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.6 | 6.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 2.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 3.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 1.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.5 | 5.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 2.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 1.5 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.4 | 2.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.4 | 1.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 1.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 0.8 | GO:0051379 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.2 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.4 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 3.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 4.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 8.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 3.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 2.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 5.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.2 | 3.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 4.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 1.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.8 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 0.4 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.1 | 0.6 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 7.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 1.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.7 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 5.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 3.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 2.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 4.0 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 3.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 2.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.3 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 4.7 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.1 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 4.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 4.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 3.8 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 8.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 1.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 5.6 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.0 | 0.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 3.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 1.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 2.3 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 1.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 5.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 3.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 8.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 3.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 4.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 5.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 7.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 6.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 5.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 6.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 3.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 6.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 9.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 10.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 4.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 5.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 2.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 4.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 2.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 3.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |